The Global Intravenous Solutions Market size was valued at USD 11.4 billion in 2018 and is expected to reach USD 13.8 billion by 2028, growing at a CAGR of 3.6% from 2021-2028. The growth can be attributed to the rising number of chronic diseases such as diabetes mellitus type II that are increasing the demand for IV solutions globally which in turn is driving the growth of this market during the forecast period 2021-2028.
Intravenous Solutions are liquids that medication and other substances can be dissolved in, to deliver them intravenously. They put the fluid directly into a vein through a needle or catheter. Intravenous solutions are used for medications such as chemotherapy drugs, which cannot be taken orally because they are not absorbed well by the intestinal lining (the stomach mucosa).
On the basis of Types, the market is segmented into Crystalloids, Colloids, and Others.
Crystalloids are a type of fluid solution that contains salts and other minerals. They help balance the body's fluids by adding electrolytes, which may be lost during illness or injury. In most cases, doctors prescribe crystalloid solutions for patients who've undergone surgery to replace cells and blood vessels in their bodies with plastic substitutes.
Colloids are a type of IV solution that is administered intravenously and can be classified as either synthetic or natural. Synthetic colloids, such as Albumin and Dextran, have a smaller molecular size than blood plasma proteins while Natural Colloid sources like Gelatin Powder have the same motional properties in liquid form. The latter requires more processing before it can be used for infusion purposes because gelatin contains high amounts of denatured protein chains which need to be broken down by heating and cooling.
On the basis of Application, the market is segmented into Basic IV Solutions, Nutrient Infusion Solution, and Others. The Basic IV Solutions segment accounted for the largest share of global revenues due to its extensive use in hospitals.
Intravenous Solutions are used as a supplement while intravenously providing fluids, nutrition, and medications in the form of IV bags. Intravenous solutions may also be given to patients who cannot swallow their food or medication for any reason. The application is primarily used by physicians, nurses, and other healthcare personnel when they need to administer large doses of prescribed medicines with minimal risk of side effects or complications from oral administration.
Intravenous Solutions are used as a nutrient therapy to provide the body with essential minerals, vitamins, and nutrients. Nutrient infusions are an alternative way to deliver nutrition by combining different types of Intravenous Solutions such as glucose solution (crystalloids), amino acid solution (colloid), and lipid emulsion.
On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American market is projected to witness unparalleled growth on account of the increasing life expectancy rates as well as the rising expenditure by patients and governments. The Asia Pacific market is projected to witness significant growth on account of the changing economic environment in developing countries such as India and China.
The major growth drivers for this market are an increase in government initiatives, advancements in technology, increasing incidence of chronic disease such as diabetes mellitus and cancer, rising prevalence of infectious diseases including HIV/AIDS which leads to increased use of intravenous fluids (IV) during illness treatment among others.
Up Market Research published a new report titled “Intravenous Solutions Sales Market research report which is segmented by Types (Crystalloids, Colloids, Others), By Applications (Basic IV Solutions, Nutrient Infusion Solution, Others), By Players/Companies Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, Fresenius Kabi, JW Life Science, B. Braun Melsungen”.
|Report Attributes||Report Details|
|Report Title||Intravenous Solutions Sales Market Research Report|
|By Type||Crystalloids, Colloids, Others|
|By Application||Basic IV Solutions, Nutrient Infusion Solution, Others|
|By Companies||Baxter, Kelun Group, Fresenius Kabi, Otsuka, ICU Medical, Fresenius Kabi, JW Life Science, B. Braun Melsungen|
|Regions Covered||North America, Europe, APAC, Latin America, MEA|
|Historical Year||2018 to 2019 (Data from 2010 can be provided as per availability)|
|Number of Pages||248|
|Number of Tables & Figures||174|
|Customization Available||Yes, the report can be customized as per your need.|
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Crystalloids, Colloids, Others and By Application Basic IV Solutions, Nutrient Infusion Solution, Others.
Some of the companies that are profiled in this report are:
Intravenous Solutions Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Intravenous Solutions Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Intravenous Solutions Sales Market Report:
Some other reports from this category!